Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.77 USD | +2.77% | -3.23% | -4.35% |
05-09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
04-30 | INmune Bio, Inc. Provides Update on Two Patients from the Phase 1b Alzheimer's Disease Trial | CI |
Sales 2024 * | 37.33K 51.08K | Sales 2025 * | 57.5K 78.68K | Capitalization | 213M 291M |
---|---|---|---|---|---|
Net income 2024 * | -41M -56.1M | Net income 2025 * | -39M -53.36M | EV / Sales 2024 * | 5,701 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3,701 x |
P/E ratio 2024 * |
-4.85
x | P/E ratio 2025 * |
-5.51
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.8% |
Latest transcript on INmune Bio, Inc.
1 day | +2.77% | ||
1 week | -3.23% | ||
Current month | -9.04% | ||
1 month | +1.99% | ||
3 months | -10.77% | ||
6 months | +54.96% | ||
Current year | -4.35% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 10.77 | +2.77% | 106,815 |
24-05-08 | 10.48 | -6.26% | 128,190 |
24-05-07 | 11.18 | -0.18% | 63,843 |
24-05-06 | 11.2 | -3.20% | 119,738 |
24-05-03 | 11.57 | +3.95% | 124,759 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.35% | 213M | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.57% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- INMB Stock